{"contentid": 488325, "importid": NaN, "name": "India approves Russia's Sputnik V coronavirus vaccine", "introduction": "Russia\u00e2\u0080\u0099s homegrown coronavirus vaccine, Sputnik V, has won approval in India, making it the third vaccine against the disease to be approved in the country.", "content": "<p><span style=\"font-weight: 400;\">Russia&rsquo;s homegrown coronavirus vaccine, Sputnik V, has won approval in India, making it the third vaccine against the disease to be approved in the country.</span></p>\n<p><span style=\"font-weight: 400;\">Backed and promoted by Russia&rsquo;s sovereign wealth fund, the Russian Direct Investment Fund (RDIF), the vaccine has been shown in Phase III tests to be safe and highly effective.</span></p>\n<p><span style=\"font-weight: 400;\">The vaccine originally attracted controversy, having been expeditiously waved through by Russia&rsquo;s medicines regulator and subsequently celebrated as a symbol of Russian national accomplishment.</span></p>\n<p><span style=\"font-weight: 400;\">However, as late stage data have emerged supporting the safety and efficacy of the vaccine, it has increasingly received global acceptance, with 60 mainly lower-income countries granting regulatory approval.</span></p>\n<p><span style=\"font-weight: 400;\">Faced with a shortage of supplies, countries in Europe have also discussed ordering stocks of the vaccine.&nbsp;</span></p>\n<p><span style=\"font-weight: 400;\">The European Medicines Agency </span><a href=\"https://www.thepharmaletter.com/article/ema-starts-rolling-review-of-the-sputnik-v-covid-19-vaccine\"><span style=\"font-weight: 400;\">initiated a rolling review</span></a><span style=\"font-weight: 400;\"> of Sputnik V in early March, with RDIF stating that &ldquo;vaccine partnerships should be above politics,&rdquo; adding, &ldquo;we would be able to provide vaccine for 50 million Europeans starting from June 2021.&rdquo;</span></p>\n<h2><strong>Indian approval</strong></h2>\n<p><span style=\"font-weight: 400;\">While Sputnik V has thus far secured approval in a series of smaller countries, the decision from the Drug Controller General of India (DCGI) opens up a much larger market for the product.</span></p>\n<p><span style=\"font-weight: 400;\">India has been struggling with a resurgence of the novel coronavirus, and has suspended exports of stocks, including AstraZeneca (LSE: AZN) and Oxford University&rsquo;s jab, in order to focus on domestic use.</span></p>\n<p><span style=\"font-weight: 400;\">The vaccine has been registered in India under the emergency use authorization procedure based on results of clinical trials in Russia as well as positive data of additional Phase III local clinical trials in India, conducted in partnership with Dr Reddy's Laboratories (BSE: 500124).</span></p>\n<p><span style=\"font-weight: 400;\">India is already the leading production hub for the vaccine, with the RDIF having reached deals with multiple pharmaceutical companies in the country to produce more than 850 million doses per year.</span></p>\n<p>RDIF chief executive Kirill Dmitriev described the approval as \"a major milestone as Russia and India have been developing an extensive cooperation on clinical trials of Sputnik V in India and its local production.\"</p>\n<p>He added: \"The Russian vaccine has efficacy of 91.6% and provides full protection against severe cases of COVID-19 as demonstrated by the data published in one of the leading medical journals The Lancet.\"</p>", "date": "2021-04-13 12:35:00", "meta_title": NaN, "meta_keywords": "vaccine, India, Sputnik, approval, coronavirus, Russias, country, RDIF, countries, approved, disease, making, homegrown, Russia, approves, fund, Russian", "meta_description": "Russia\u00e2\u0080\u0099s homegrown coronavirus vaccine, Sputnik V, has won approval in India, making it the third vaccine against the disease to be approved in the country.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-13 12:07:22", "updated": "2021-04-13 12:35:29", "access": NaN, "url": "https://www.thepharmaletter.com/article/india-approves-russia-s-sputnik-v-coronavirus-vaccine", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "vaccine_sputnik_big.jpg", "image2id": "vaccine_sputnik_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Vaccines", "topic_tag": "Coronavirus, Focus On, Public health, Regulation", "geography_tag": "India, Russia", "company_tag": "Gamaleya, RDIF", "drug_tag": "Sputnik V", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-13 12:35:00"}